LAVAL, QC, April 17, 2019 /CNW/ - Crescita Therapeutics
Inc. (TSX: CTX) (OTC US: CRRTF) (Crescita or the Company), a
Canadian commercial dermatology company, is pleased to announce
that its President and CEO, Serge
Verreault will be presenting at the upcoming Bloom Burton
& Co. Healthcare Investor Conference which will be held from
April 30 to May 1, 2019 in
Toronto, Ontario.
Mr. Verreault will discuss recent business highlights and the
Company's growth strategy. Members of Crescita's management team
will also be available for one-on-one investor meetings on both
days of the conference.
The details of Crescita's presentation are:
Date: Tuesday, April 30,
2019
Time: 3:00 PM EST
Location: Metro Toronto
Convention Centre, 255 Front St W, Toronto, Ontario
About the Conference
The Bloom Burton & Co.
Healthcare Investor Conference brings together U.S., Canadian and
international investors who are interested in the latest
developments in the Canadian healthcare sector. Attendees will have
an opportunity to obtain corporate updates from premier Canadian
publicly traded and private companies through presentations and
private meetings.
About Bloom Burton & Co.
Bloom Burton & Co.
(Bloom Burton Securities Inc.) is a firm dedicated to accelerating
returns in the healthcare sector for both investors and companies.
Bloom Burton has an experienced team of medical, scientific,
pharmaceutical, legal and capital markets professionals who perform
a deep level of diligence, which combined with our creative and
entrepreneurial approach, assists our clients in achieving the
right monetization events. Bloom Burton and its affiliates provide
capital raising, M&A advisory, equity research, business
strategy and scientific consulting, advisory on direct investing
and company creation and incubation services. Bloom Burton
Securities Inc. is a member of the Investment Industry Regulatory
Organization of Canada (IIROC) and
is also a member of the Canadian Investor Protection Fund
(CIPF).
About Crescita Therapeutics Inc.
Crescita
(TSX: CTX and OTC US: CRRTF) is a publicly traded, Canadian
commercial dermatology company with a portfolio of non-prescription
skincare products and prescription drug products for the treatment
and care of skin conditions and diseases and their
symptoms. Crescita owns multiple proprietary drug delivery
platforms that support the development of patented formulations
that can facilitate the delivery of active drugs into or through
the skin. Please visit
www.crescitatherapeutics.com for additional
information.
Forward-Looking Statements
This press release
contains "forward-looking information" as defined under Canadian
securities laws (collectively, "forward-looking statements"). The
words "plans", "expects", "does not expect", "goals", "seek",
"strategy", "future", "estimates", "intends", "anticipates", "does
not anticipate", "projected", "believes" or variations of such
words and phrases or statements to the effect that certain actions,
events or results "may", "will", "could", "would", "should",
"might", "likely", "occur", "be achieved" or "continue" and similar
expressions identify forward-looking statements. In addition, any
statements that refer to expectations, intentions, projections or
other characterizations of future events or circumstances contain
forward-looking statements.
Forward-looking statements are not historical facts but
instead represent management's expectations, estimates, projections
and assumptions regarding future events or circumstances. Such
forward-looking statements are qualified in their entirety by the
inherent risks, uncertainties and changes in circumstances
surrounding future expectations which are difficult to predict and
many of which are beyond the control of the Company.
Forward-looking statements are necessarily based on a number of
estimates and assumptions that, while considered reasonable by
management of the Company as of the date of this press release, are
inherently subject to significant business, economic and
competitive uncertainties and contingencies. Material factors and
assumptions used to develop the forward-looking statements, and
material risk factors that could cause actual results to differ
materially from the forward-looking statements, include but are not
limited to changes in the business or affairs of Crescita; the
ability of Crescita's licensees to successfully market its
products; competitive factors in the industries in which Crescita
operates; relationships with customers, suppliers and licensees;
changes in legal and regulatory requirements; foreign exchange and
interest rates; prevailing economic conditions; and other factors,
many of which are beyond the control of Crescita. Additional
factors that could cause Crescita's actual results and financial
condition to differ materially from those indicated in the
forward-looking statements include, among others, the risk factors
included in Crescita's most recent Annual Information Form dated
March 18, 2019 under the heading
"Risks Factors", and as described from time to time in the reports
and disclosure documents filed by Crescita with Canadian securities
regulatory agencies and commissions. These and other factors should
be considered carefully, and readers should not place undue
reliance on Crescita's forward-looking statements, as
forward-looking statements involve significant risks and
uncertainties. Forward-looking statements should not be read as
guarantees of future performance or results and will not
necessarily be accurate indications of whether or not the times at
or by which such performance or results will be achieved.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/crescita-therapeutics-to-present-at-the-2019-bloom-burton--co-healthcare-investor-conference-in-toronto-300833549.html
SOURCE Crescita Therapeutics Inc.